YP
Yogesh Purshottam Harwani
About Yogesh Purshottam Harwani
Yogesh Purshottam Harwani has 10 years in corporate governance. Holds Director and Designated Partner roles. Currently with 4 companies, including Onempire Hospitals Private Limited and Morbus Medicines Private Limited. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Onempire Hospitals Private Limited
U86100GJ2024PTC149509
|
Director | 10 Feb 2025 | 2024 | Active |
Morbus Medicines Private Limited
U51909GJ2021PTC125976
|
Director | 29 Sep 2021 | 2021 | Active |
| Partner | 20 Mar 2025 | 2024 | Active | |
Noble Gastro Associates Private Limited
U86100GJ2023PTC145009
|
Director | 26 Sep 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Noble Gastro Associates Llp
AAF-1867
|
Designated Partner | 19 Nov 2015 | 2015 | Converted And Dissolved |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Yogesh Purshottam Harwani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Yogesh Purshottam Harwani
Yogesh Purshottam Harwani has 10 years in corporate governance. Holds Director and Designated Partner roles. Currently with 4 companies, including Onempire Hospitals Private Limited and Morbus Medicines Private Limited. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.
Yogesh Purshottam Harwani is associated with 4 companies as Director and Designated Partner.
Yogesh Purshottam Harwani has expertise in General Business.
Yogesh Purshottam Harwani has 10 years in corporate governance.